Catalyst Wire Dossier Catalyst Wire Dossier

CAR-CD19 T cells

CD19-directed chimeric antigen receptor T cells · RenJi Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR-CD19 T cells, covering 2016-10-14 to 2016-10-14. Get the full timeline:

Most recent: Clinical Trial Update: CD19-redirected Autologous Cells (CAR-CD19 T Cells) [Phase 1]

See pricing